Pap Smear Frequency: What the Current Guidelines Actually Say

What is the recommended Pap smear schedule by age?

Current guidance from the U.S. Preventive Services Task Force establishes the following schedule 1Ref 1US Preventive Services Task Force (2018).Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement.Age-stratified Pap smear and co-testing schedule (ages 21–29 every 3 years; ages 30–65 co-testing or HPV alone every 5 years); rationale for longer intervals based on slow disease progression; criteria for stopping after 65:

Ages 21–29: Pap test alone, every 3 years. HPV testing is not routinely added in this age group because HPV infection is very common and usually clears on its own in younger adults. Routine screening before age 21 is not recommended — the risk of screen-induced harm from unnecessary follow-up procedures outweighs the benefit.

Ages 30–65: Three options are considered equivalent: - Pap test alone every 3 years - Pap plus HPV co-testing every 5 years - HPV test alone every 5 years

Co-testing or HPV-alone testing is generally preferred because it catches more at-risk situations with fewer visits.

After 65: Screening may stop if you have had adequate prior normal screening and no recent abnormal results. Your clinician makes this determination based on your full history.

After total hysterectomy (cervix removed): If you have no history of high-grade cervical changes or cervical cancer, routine screening is generally no longer needed.

Why did the intervals get longer — is this a cost-cutting move?

No. The shift from annual Pap smears to 3- and 5-year intervals came from studies showing that cervical cell changes develop slowly — it typically takes many years for an HPV infection to progress to a high-grade lesion, and longer still to become cancer 1Ref 1US Preventive Services Task Force (2018).Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement.Age-stratified Pap smear and co-testing schedule (ages 21–29 every 3 years; ages 30–65 co-testing or HPV alone every 5 years); rationale for longer intervals based on slow disease progression; criteria for stopping after 65.

Annual screening was catching many minor changes that would have resolved without treatment, and those findings were leading to procedures — biopsies, colposcopies, LEEP — that carry their own small risks, including to future pregnancies. The longer intervals were designed to reduce that over-treatment while still detecting genuine risk early. They are the evidence-based approach, not a compromise.

Who needs more frequent screening than the standard schedule?

Certain groups may need more frequent cervical screening based on their individual history and immune status:

• HIV-positive individuals or others who are immunocompromised: Annual Pap tests are typically recommended, at least initially, because their immune systems are less able to clear HPV and cell changes may progress more quickly 3Ref 3American College of Obstetricians and Gynecologists (2018).Gynecologic Care for Women and Adolescents with Human Immunodeficiency Virus (Practice Bulletin 167).Annual cervical cytology is recommended for HIV-positive individuals; after two consecutive normal results the interval may be extended to every 3 years based on immune status and clinical judgment. Your care team familiar with your immune status will set the appropriate schedule.
• History of high-grade cervical dysplasia (CIN2, CIN3) or cervical cancer: Closer follow-up for several years after treatment is standard, even when subsequent tests come back normal.
• Prior DES (diethylstilbestrol) exposure before birth: Those born to mothers who took DES before 1971 face a higher risk for a rare vaginal cancer and need specialized screening.

For women with HIV, clinicians often follow a schedule of annual cervical cytology after two consecutive normal results, then potentially extending to every 3 years — but the specific protocol comes from the managing provider, not a general guideline.

What happens if a Pap result is abnormal?

An abnormal Pap result does not mean cancer. The most common finding is ASCUS (atypical squamous cells of undetermined significance), which often resolves on its own. More specific findings carry different implications:

• LSIL (low-grade squamous intraepithelial lesion): Often monitored with closer follow-up or an HPV reflex test
• HSIL (high-grade squamous intraepithelial lesion): Warrants prompt colposcopy — a closer visual examination of the cervix

If colposcopy reveals an area that looks abnormal, a small biopsy may be taken to determine the exact type of cell change. Your clinician will explain the specific finding and what follow-up is needed. The system is designed to catch changes early, at a stage when they are easy to monitor or treat 2Ref 2American College of Obstetricians and Gynecologists (2023).Colposcopy and Cervical Biopsies (Patient FAQ).What happens after an abnormal Pap result: colposcopy, biopsy, and follow-up steps.

For information on what colposcopy involves and what to expect, ACOG provides patient-facing guidance 2Ref 2American College of Obstetricians and Gynecologists (2023).Colposcopy and Cervical Biopsies (Patient FAQ).What happens after an abnormal Pap result: colposcopy, biopsy, and follow-up steps.

Does the HPV vaccine change whether you need Pap smears?

Receiving the HPV vaccine does not eliminate the need for cervical cancer screening. The vaccine protects against the HPV types most likely to cause cervical cancer, but it does not cover every type, and it does not protect against infections that occurred before vaccination. Cervical cancer screening remains important regardless of vaccination status, on the same schedule as unvaccinated individuals.